@misc{discovery10047475,
         address = {Neuromuscular Disorders},
       booktitle = {11th Annual UK Neuromuscular Translational Research Conference},
           pages = {S27--S27},
          volume = {28},
           title = {RCT of Bumetanide in Hypokalaemic Periodic Paralysis (HypoPP) using abductor digiti minimi compound muscle action potential (CMAP) as an objective outcome measure},
            note = {This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.},
         journal = {Neuromuscular Disorders},
       publisher = {Elsevier},
           month = {April},
            year = {2018},
          number = {S1},
          author = {Scalco, RS and Morrow, J and Manole, A and Skorupinska, I and Bellin, A and Ricciardi, F and Matthews, E and Hanna, M and Fialho, D},
            issn = {0960-8966},
             url = {https://doi.org/10.1016/S0960-8966(18)30370-5},
        keywords = {Periodic Paralysis, Channelopathy, Hypokalaemic Periodic Paralysis, CMAP, Phase II, Drug repurposing study, Long exercise test, Neurophysiology, Outcome measure, Treatment}
}